100 related articles for article (PubMed ID: 1631737)
21. Mass infection with Entamoeba histolytica in a Japanese institution for individuals with mental retardation: epidemiology and control measures.
Nishise S; Fujishima T; Kobayashi S; Otani K; Nishise Y; Takeda H; Kawata S
Ann Trop Med Parasitol; 2010 Jul; 104(5):383-90. PubMed ID: 20819306
[TBL] [Abstract][Full Text] [Related]
22. [Amebiasis: implications of the recognition of Entamoeba dispar and the identification of Entamoeba moshkovskii in humans].
Chacín-Bonilla L
Invest Clin; 2010 Jun; 51(2):239-56. PubMed ID: 20928980
[TBL] [Abstract][Full Text] [Related]
23. [Entamoeba histolytica: a standing threat].
Conde-Bonfil MC; de la Mora-Zerpa C
Salud Publica Mex; 1992; 34(3):335-41. PubMed ID: 1615351
[TBL] [Abstract][Full Text] [Related]
24. [Amebiasis. Its epidemiology today].
Gutiérrez Trujillo G; Muñoz Hernández O
Rev Gastroenterol Mex; 1989; 54(3):145-56. PubMed ID: 2554461
[No Abstract] [Full Text] [Related]
25. High seropositivity of Japanese homosexual men for amebic infection.
Takeuchi T; Okuzawa E; Nozaki T; Kobayashi S; Mizokami M; Minoshima N; Yamamoto M; Isomura S
J Infect Dis; 1989 Apr; 159(4):808. PubMed ID: 2538524
[No Abstract] [Full Text] [Related]
26. [Immunization against Entamoeba histolytica. Current state and conclusive perspectives].
Sepúlveda B
Gac Med Mex; 1979 May; 115(5):235-7. PubMed ID: 225237
[No Abstract] [Full Text] [Related]
27. Entamoeba histolytica and/or Entamoeba dispar: infection frequency in HIV+/AIDS patients in Mexico city.
Moran P; Ramos F; Ramiro M; Curiel O; González E; Valadez A; Gómez A; García G; Melendro EI; Ximénez C
Exp Parasitol; 2005 Jul; 110(3):331-4. PubMed ID: 15955334
[TBL] [Abstract][Full Text] [Related]
28. Serological differentiation between zymodemes of Entamoeba histolytica.
Demedts P; Coene J; Wéry M
J Trop Med Hyg; 1989 Apr; 92(2):121-2. PubMed ID: 2540346
[No Abstract] [Full Text] [Related]
29. New evidence of Entamoeba histolytica infections in pre-Columbian and colonial cemeteries in the Caribbean.
Le Bailly M; Romon T; Kacki S
J Parasitol; 2014 Oct; 100(5):684-6. PubMed ID: 24766261
[TBL] [Abstract][Full Text] [Related]
30. [National serologic survey. I. Study of antibodies against E. histolytica in a semirural locality on the Gulf of Mexico Coast].
Gutiérrez G; Margáin JC; Castañeda R; Enríquez O; Aubanel M; Sepúlveda B
Arch Invest Med (Mex); 1974; 5 SUPPL 2():475-80. PubMed ID: 4376934
[No Abstract] [Full Text] [Related]
31. Specific antiamebic serum antibodies in Mexican puerperae and their newborns.
Aguirre-Cruz L; López-Revilla R; Zacapa E; Martínez C; Muñoz O
Adv Exp Med Biol; 1995; 371B():949-52. PubMed ID: 7502933
[No Abstract] [Full Text] [Related]
32. Humoral immune response to E. histolytica/E. dispar during the first year of life. A cohort study.
Gómez-Delgado A; Martínez-García MD; Garduño-Espinosa J; Garduño-Rodríguez G; Valadez-Salazar A; Leyva O; Cedillo-Rivera R; Ximénez C; Muñoz O
Arch Med Res; 1997; 28 Spec No():325-6. PubMed ID: 9033119
[No Abstract] [Full Text] [Related]
33. Inhibition of Entamoeba histolytica proteolytic activity by human salivary IgA antibodies.
Guerrero-Manríquez GG; Sánchez-Ibarra F; Avila EE
APMIS; 1998 Nov; 106(11):1088-94. PubMed ID: 9890272
[TBL] [Abstract][Full Text] [Related]
34. Determination of the prevalence of Entamoeba histolytica and E. dispar in the pernambuco state of northeastern Brazil by a polymerase chain reaction.
Pinheiro SM; Carneiro RM; Aca IS; Irmão JI; Morais MA; Coimbra MR; Carvalho LB
Am J Trop Med Hyg; 2004 Feb; 70(2):221-4. PubMed ID: 14993636
[TBL] [Abstract][Full Text] [Related]
35. Serologic characterization of Entamoeba histolytica asymptomatic carriers from a community of Puebla state, Mexico.
Sánchez-Guillén MC; Merino-Guzmán G; Pérez-Fuentes R; Rosales-Encina JL; Talamás-Rohana P
Arch Med Res; 1997; 28 Spec No():322-4. PubMed ID: 9033118
[No Abstract] [Full Text] [Related]
36. Cost-effectiveness analysis of treatment of E. histolytica/E. dispar cyst carriers.
Garduño-Espinosa J; Martínez-García MC; Valadez-Salazar A; Padilla G; Cedillo-Rivera R; Muñoz O
Arch Med Res; 1997; 28 Spec No():293-4. PubMed ID: 9033106
[No Abstract] [Full Text] [Related]
37. Amoebiasis in foreign students.
Giboda M; Ditrich O; Vokurková-Vrchotová N
Folia Parasitol (Praha); 1990; 37(2):97-104. PubMed ID: 2370032
[TBL] [Abstract][Full Text] [Related]
38. Protective immunity to amebiasis: new insights and new challenges.
Stanley SL
J Infect Dis; 2001 Aug; 184(4):504-6. PubMed ID: 11471109
[TBL] [Abstract][Full Text] [Related]
39. Detection of Entamoeba histolytica/dispar in stool specimens by using enzyme-linked immunosorbent assay in the population of Jeddah City, Saudi Arabia.
Barnawi AB; Tonkal AM; Fouad MA; Al-Braiken FA
J Egypt Soc Parasitol; 2007 Apr; 37(1):143-50. PubMed ID: 17580574
[TBL] [Abstract][Full Text] [Related]
40. Amebiasis among persons who sought voluntary counseling and testing for human immunodeficiency virus infection: a case-control study.
Hung CC; Wu PY; Chang SY; Ji DD; Sun HY; Liu WC; Wu CH; Chang SC
Am J Trop Med Hyg; 2011 Jan; 84(1):65-9. PubMed ID: 21212204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
